Comparative Effectiveness and Safety of Drugs used in Rare Neuromuscular and Neurodegenerative Diseases (CAESAR)

10/11/2020
23/04/2024
EU PAS number:
EUPAS37983
Study
Planned
Documents
Study protocol
Study results
Study report
Other information